Zobrazeno 1 - 10
of 61
pro vyhledávání: '"Tom R. Miller"'
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 72:1502-1507
Purpose To document changes in cervical tumor 18 -F-fluorodeoxyglocose (FDG) uptake during radiation therapy and to correlate those changes with post-treatment tumor response and survival outcome. Methods and Materials A total of 36 patients with Sta
Autor:
Imran Zoberi, Richard Laforest, Tom R. Miller, Perry W. Grigsby, M. Vicic, Sasa Mutic, Lilie L. Lin, Daniel A. Low
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 67:91-96
Purpose: A dosimetric study was conducted to compare intracavitary brachytherapy using both a conventional and a custom loading intended to cover a positron emission tomography (PET)-defined tumor volume in patients with cervix cancer. Methods and Ma
Autor:
Michael M. Graham, Kay H. Vydareny, Alan H. Maurer, Tom R. Miller, Jay A. Harolds, Milton J. Guiberteau
Publikováno v:
Academic Radiology. 13:1405-1409
Rationale and Objectives There have been many recent changes in governmental regulations affecting nuclear medicine/nuclear radiology practice and training requirements. This article summarizes the background for these changes, and summarizes the new
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 65:177-181
Purpose: To evaluate the physiologic tumor volume response during treatment in cervical cancer using 18F-fluorodeoxyglucose positron emission tomography (FDG-PET). Patients and Methods: This was a prospective study of 32 patients. Physiologic tumor v
Autor:
Richard Laforest, Imran Zoberi, Lilie L. Lin, Tom R. Miller, Sasa Mutic, Perry W. Grigsby, Daniel A. Low, M. Vicic, Robert S. Malyapa
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 63:1494-1501
Purpose: To evaluate the utility of sequential 18 F-fluorodeoxyglucose positron emission tomography (FDG-PET) imaging for brachytherapy treatment planning in patients with carcinoma of the cervix. Methods and Materials: Twenty-four patients with carc
Autor:
Farrokh Dehdashti, Tom R. Miller, Jeffrey D. Bradley, Wade L. Thorstad, Barry A. Siegel, Sasa Mutic, Rudi J. Bertrand, Walter R. Bosch
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 59:78-86
Purpose Locoregional failure remains a significant problem for patients receiving definitive radiation therapy alone or combined with chemotherapy for non–small-cell lung cancer (NSCLC). Positron emission tomography (PET) with [ 18 F]fluoro-2-deoxy
Autor:
Farrokh Dehdashti, Jacqueline Esthappan, Daniel A. Low, Imran Zoberi, Walter R. Bosch, Robert S. Malyapa, Sasa Mutic, Perry W. Grigsby, Tom R. Miller
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 58:1289-1297
Purpose Computed tomography (CT)/positron emission tomography (PET)-guided intensity-modulated radiotherapy of the paraaortic lymph nodes (PALNs) has been proposed for patients with cervical carcinoma and paraaortic metastasis. This investigation att
Autor:
Imran Zoberi, Daniel A. Low, Perry W. Grigsby, Farrokh Dehdashti, Robert S. Malyapa, Jacqueline Esthappan, Walter R. Bosch, Sasa Mutic, Tom R. Miller
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 55:28-35
Purpose: To evaluate a treatment planning method for dose escalation to the para-aortic lymph nodes (PALNs) based on positron emission tomography (PET) with intensity-modulated radiotherapy (IMRT) for cervical cancer patients with PALN involvement. O
Autor:
Daniel A. Low, Imran Zoberi, Walter R. Bosch, Robert S. Malyapa, Sasa Mutic, Perry W. Grigsby, Richard Laforest, Tom R. Miller
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 54:1140-1146
Purpose: To compare conventional two-dimensional (2D) orthogonal radiography-based brachytherapy treatment planning for cervical cancer with a three-dimensional (3D) treatment planning technique based on 18 F-fluoro-deoxyglucose-positron emission tom
Publikováno v:
Molecular Imaging & Biology. 4:301-310
Purpose: This work evaluates positron emission tomography (PET) with 2-deoxy-2-[ 18 F]fluoro-D-glucose (FDG) in assessing response to therapy in patients with esophageal cancer. Procedures: Twenty-four patients underwent FDG-PET before (pre-Rx) and a